Try our beta test site
360 studies found for:    "Transitional cell carcinoma"
Show Display Options
Rank Status Study
1 Unknown  Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
Condition: Transitional Cell Carcinoma
Interventions: Drug: Cabazitaxel;   Other: Best Supportive Care
2 Active, not recruiting Neoadjuvant Erlotinib (Tarceva) in Transitional Cell Carcinoma
Condition: Transitional Cell Carcinoma
Intervention: Drug: Erlotinib Hydrochloride
3 Unknown  Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)
Condition: Urothelium Transitional Cell Carcinoma
Interventions: Drug: Cabazitaxel;   Drug: Vinflunine
4 Completed JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin
Condition: Bladder Transitional Cell Carcinoma Stage IV
Interventions: Drug: Vinflunine, Gemcitabine;   Drug: Vinflunine, Carboplatin
5 Completed
Has Results
Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder
Condition: Transitional Cell Carcinoma of the Bladder
Interventions: Drug: Dasatinib;   Procedure: Radical Cystectomy
6 Active, not recruiting Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium
Condition: Metastatic Transitional Cell Carcinoma of the Urothelium
Intervention: Drug: Buparlisib
7 Not yet recruiting Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder
Condition: Muscle-invasive Transitional Cell Carcinoma of the Bladder
Interventions: Biological: REOLYSIN®;   Drug: Gemcitabine;   Drug: Cisplatin
8 Completed Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC
Condition: Transitional Cell Carcinoma
Intervention: Drug: Gemcitabine, Ifosfamide
9 Completed Weekly TP-HDFL in the Treatment of Advanced TCC
Condition: Transitional Cell Carcinoma
Intervention: Drug: Paclitaxel, Cisplatin, 5-Fluorouracil
10 Completed Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma
Condition: Transitional Cell Carcinoma of Urinary Tract
Intervention: Device: Optical Coherence Tomography
11 Active, not recruiting Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer;   Metastatic Transitional Cell Carcinoma
Intervention: Drug: Everolimus
12 Withdrawn Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
Condition: Urothelial Carcinoma
Interventions: Drug: Docetaxel;   Drug: ASA404
13 Completed JAVLOR® Online Non-Interventional Trial
Condition: Transitional Cell Carcinoma
Intervention:
14 Active, not recruiting Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
Condition: Urothelial Carcinoma
Interventions: Drug: Cabazitaxel;   Drug: Neulasta;   Procedure: CT Scan;   Biological: Blood Draw
15 Active, not recruiting BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma
Condition: Urothelial Carcinoma
Intervention: Drug: BIBF1120
16 Completed A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)
Condition: Urothelial Carcinoma
Intervention: Drug: CABAZITAXEL
17 Completed Single Agent Abraxane as Second Line Therapy in Bladder Cancer
Condition: Transitional Cell Carcinoma
Intervention: Drug: Paclitaxel
18 Completed A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy
Condition: Transitional Cell Carcinoma
Intervention: Drug: RAD001
19 Withdrawn Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma
Condition: Urothelial Carcinoma
Interventions: Drug: AMG 386;   Drug: Docetaxel
20 Recruiting A Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Urothelial Carcinoma
Condition: Urothelial Carcinoma
Intervention: Drug: INCB054828

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.